These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


44 related items for PubMed ID: 9094149

  • 21. Increases in the density of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for corticotropin-releasing factor in sustained elevation.
    Mohila CA, Onn SP.
    Cereb Cortex; 2005 Mar; 15(3):262-74. PubMed ID: 15238432
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats.
    Bowyer JF, Frame LT, Clausing P, Nagamoto-Combs K, Osterhout CA, Sterling CR, Tank AW.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1074-85. PubMed ID: 9694971
    [Abstract] [Full Text] [Related]

  • 25. Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication.
    Swerdlow NR, Hauger R, Irwin M, Koob GF, Britton KT, Pulvirenti L.
    Neuropsychopharmacology; 1991 Aug; 5(1):23-31. PubMed ID: 1657016
    [Abstract] [Full Text] [Related]

  • 26. Amphetamine-induced dyskinesia in the transplanted hemi-Parkinsonian mouse.
    Smith GA, Heuer A, Klein A, Vinh NN, Dunnett SB, Lane EL.
    J Parkinsons Dis; 2012 Aug; 2(2):107-13. PubMed ID: 23933747
    [Abstract] [Full Text] [Related]

  • 27. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 28. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome.
    Harris GC, Aston-Jones G.
    Nature; 1994 Sep 08; 371(6493):155-7. PubMed ID: 7915401
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
    Giambalvo CT.
    Synapse; 2003 Aug 08; 49(2):125-33. PubMed ID: 12740868
    [Abstract] [Full Text] [Related]

  • 30. Amphetamine withdrawal: depression and M.H.P.G. excretion.
    Schildkraut JJ, Watson R, Draskoczy PR.
    Lancet; 1971 Aug 28; 2(7722):485-6. PubMed ID: 4105344
    [No Abstract] [Full Text] [Related]

  • 31. Amphetamine abuse. Pattern and effects of high doses taken intravenously.
    Kramer JC, Fischman VS, Littlefield DC.
    JAMA; 1967 Jul 31; 201(5):305-9. PubMed ID: 6071725
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC, Kalivas PW.
    J Pharmacol Exp Ther; 1995 Nov 31; 275(2):1019-29. PubMed ID: 7473128
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dopamine partial agonist reverses amphetamine withdrawal in rats.
    Orsini C, Koob GF, Pulvirenti L.
    Neuropsychopharmacology; 2001 Nov 31; 25(5):789-92. PubMed ID: 11682262
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 3.